Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Microwell devices with finger-like channels for long-term imaging of HIV-1 expression kinetics in primary human lymphocytes.

Razooky BS, Gutierrez E, Terry VH, Spina CA, Groisman A, Weinberger LS.

Lab Chip. 2012 Nov 7;12(21):4305-12. doi: 10.1039/c2lc40170c.

2.

Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.

Hermankova M, Siliciano JD, Zhou Y, Monie D, Chadwick K, Margolick JB, Quinn TC, Siliciano RF.

J Virol. 2003 Jul;77(13):7383-92.

3.

Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence.

Mahlknecht U, Deng C, Lu MC, Greenough TC, Sullivan JL, O'Brien WA, Herbein G.

J Immunol. 2000 Dec 1;165(11):6437-46.

4.

Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.

Saleh S, Wightman F, Ramanayake S, Alexander M, Kumar N, Khoury G, Pereira C, Purcell D, Cameron PU, Lewin SR.

Retrovirology. 2011 Oct 12;8:80. doi: 10.1186/1742-4690-8-80.

5.

Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique.

Martrus G, Niehrs A, Cornelis R, Rechtien A, García-Beltran W, Lütgehetmann M, Hoffmann C, Altfeld M.

J Virol. 2016 Sep 29;90(20):9018-28. doi: 10.1128/JVI.01448-16. Print 2016 Oct 15.

6.
7.

Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.

Zhou X, Cui Y, Huang X, Yu Z, Thomas AM, Ye Z, Pardoll DM, Jaffee EM, Cheng L.

Hum Gene Ther. 2003 Jul 20;14(11):1089-105.

PMID:
12885348
8.

High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.

Iglesias-Ussel M, Vandergeeten C, Marchionni L, Chomont N, Romerio F.

J Virol. 2013 Aug;87(16):9148-58. doi: 10.1128/JVI.01297-13. Epub 2013 Jun 12.

10.

Improvement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNA.

Shunaeva A, Potashnikova D, Pichugin A, Mishina A, Filatov A, Nikolaitchik O, Hu WS, Mazurov D.

J Virol. 2015 Oct;89(20):10591-601. doi: 10.1128/JVI.01940-15. Epub 2015 Aug 12.

11.

Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction.

Tyagi M, Pearson RJ, Karn J.

J Virol. 2010 Jul;84(13):6425-37. doi: 10.1128/JVI.01519-09. Epub 2010 Apr 21.

12.

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.

Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H.

Nat Med. 2007 Oct;13(10):1241-7. Epub 2007 Sep 30.

PMID:
17906637
13.

Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay.

Fondere JM, Planas JF, Huguet MF, Baillat V, Bolos F, Reynes J, Vendrell JP.

J Clin Virol. 2004 Jan;29(1):33-8.

PMID:
14675867
14.

A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence.

Kim M, Hosmane NN, Bullen CK, Capoferri A, Yang HC, Siliciano JD, Siliciano RF.

Nat Protoc. 2014 Dec;9(12):2755-70. doi: 10.1038/nprot.2014.188. Epub 2014 Nov 6.

15.

The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.

Lucera MB, Tilton CA, Mao H, Dobrowolski C, Tabler CO, Haqqani AA, Karn J, Tilton JC.

J Virol. 2014 Sep;88(18):10803-12. doi: 10.1128/JVI.00320-14. Epub 2014 Jul 9.

16.

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, Ruff A, Hutton N, Ray S, Siliciano RF.

J Clin Invest. 2000 Apr;105(7):995-1003.

17.

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

Apolloni A, Lin MH, Sivakumaran H, Li D, Kershaw MH, Harrich D.

Hum Gene Ther. 2013 Mar;24(3):270-82. doi: 10.1089/hum.2012.176. Epub 2013 Mar 1.

18.

Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.

Keppler OT, Tibroni N, Venzke S, Rauch S, Fackler OT.

J Leukoc Biol. 2006 Mar;79(3):616-27. Epub 2005 Dec 19.

PMID:
16365153
19.

Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.

Swiggard WJ, Baytop C, Yu JJ, Dai J, Li C, Schretzenmair R, Theodosopoulos T, O'Doherty U.

J Virol. 2005 Nov;79(22):14179-88.

20.

Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.

Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, Rosenberg ES, Lichterfeld M.

J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25.

Supplemental Content

Support Center